Vanila Singh
Direttore/Membro del Consiglio presso VIRPAX PHARMACEUTICALS, INC.
Patrimonio netto: - $ in data 31/05/2024
Profilo
Vanila M.
Singh is an Independent Director at Virpax Pharmaceuticals, Inc. since 2020.
She is also an Associate Professor at Stanford University since 2004.
Additionally, she is a Member of the American Society of Anesthesiologists.
Previously, she served as an Independent Director at BioDelivery Sciences International, Inc. from 2019 to 2022.
Prior to that, she was the Chief Medical Officer at the US Department of Health & Human Services from 2017 to 2019.
Dr. Singh completed her undergraduate studies at the University of California, Berkeley.
She then pursued her graduate degree at the Keck School of Medicine of USC and obtained her doctorate from George Washington University School of Medicine & Health.
Partecipazioni note in società pubbliche
| Società | Data | Numero di azioni | Valorizzazione | Data di valutazione |
|---|---|---|---|---|
| 03/06/2024 | 0 ( -.--% ) | - $ | 31/05/2024 |
Posizioni attive di Vanila Singh
| Società | Posizione | Inizio |
|---|---|---|
| VIRPAX PHARMACEUTICALS, INC. | Direttore/Membro del Consiglio | 01/06/2020 |
American Society of Anesthesiologists
 American Society of Anesthesiologists Medical/Nursing ServicesHealth Services American Society of Anesthesiologists provides access to multiple choice questions and corresponding discussions to earn CME credits. The private company is based in Park Ridge, IL, and the CEO of the company is Paul Pomerantz. The company offers top jobs in anesthesiology and publish the highest-impact, peer-reviewed medical journal that publishes trusted evidence that transforms the practice of perioperative, critical care, and pain medicine. The company also offers clinical reviews, editorials, podcasts, infographics, and videos. | Corporate Officer/Principal | - |
| Stanford University | Corporate Officer/Principal | 01/06/2004 |
Precedenti posizioni note di Vanila Singh
| Società | Posizione | Fine |
|---|---|---|
| BIODELIVERY SCIENCES INTERNATIONAL, INC. | Direttore/Membro del Consiglio | 22/03/2022 |
| US Department of Health & Human Services (DC) | Direttore Tecnico/Scientifico/R&S | 01/07/2019 |
Formazione di Vanila Singh
| University of California, Berkeley | Undergraduate Degree |
| George Washington University School of Medicine & Health | Doctorate Degree |
| Keck School of Medicine of USC | Graduate Degree |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Società quotate in Borsa | 1 |
|---|---|
| VIRPAX PHARMACEUTICALS, INC. | Health Technology |
| Aziende private | 3 |
|---|---|
American Society of Anesthesiologists
American Society of Anesthesiologists Medical/Nursing ServicesHealth Services American Society of Anesthesiologists provides access to multiple choice questions and corresponding discussions to earn CME credits. The private company is based in Park Ridge, IL, and the CEO of the company is Paul Pomerantz. The company offers top jobs in anesthesiology and publish the highest-impact, peer-reviewed medical journal that publishes trusted evidence that transforms the practice of perioperative, critical care, and pain medicine. The company also offers clinical reviews, editorials, podcasts, infographics, and videos. | Health Services |
BioDelivery Sciences International, Inc.
 BioDelivery Sciences International, Inc. Pharmaceuticals: MajorHealth Technology BioDelivery Sciences International, Inc. operates as a pharmaceutical company engaged in the development and commercialization of new applications of approved therapeutics to address important unmet medical needs. Its products include Symproic and Belbuca. The company was founded on January 6, 1997 and is headquartered in Raleigh, NC. | Health Technology |
| US Department of Health & Human Services (DC) | Government |
- Borsa valori
- Insiders
- Vanila Singh
